Janssen Teams Up With Forma On Tumor Metabolism

 
• By Lisa LaMotta

Forma has garnered a deal with J&J subsidiary Janssen Pharmaceuticals to develop and commercialize treatments for tumor metabolism.

More from R&D

More from Pink Sheet